Modulation of P-glycoprotein function by St John's wort extract and its major constituents
- PMID: 15551196
- DOI: 10.1055/s-2004-832686
Modulation of P-glycoprotein function by St John's wort extract and its major constituents
Abstract
Introduction: Recent data suggest some relevant drug interactions caused by St John's wort extract, which can be explained by interactions with the Cytochrome P450 system or P-Glycoprotein (Pgp). Interaction with Pgp, including activation, inhibition and induction, can lead to altered plasma or brain levels of Pgp substrates. The aim of the present study was to investigate the possible interactions of St John's wort extract and most relevant constituents with the transport activity of Pgp.
Methods: We characterized the modulatory potencies in two in vitro assays using calcein-AM, first in VLB cells (a human lymphocytic leukemia cell line expressing Pgp) and second in PBCEC cells (porcine brain capillary endothelial cells).
Results: The extract, as well as some of the tested constituents modulate the transport by Pgp in the micromolecular range. Quercetin and hyperforin seem to be most potent.
Conclusions: These findings suggest the possibility of drug interactions at the level of the gastro-intestinal absorption of drugs. Plasma levels of the constituents of St John's wort are very likely too low to interfere with Pgp at the blood-brain-barrier with the possible exception of quercetin.
Similar articles
-
Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.Drug Metab Dispos. 2005 Apr;33(4):547-54. doi: 10.1124/dmd.104.002485. Epub 2005 Jan 7. Drug Metab Dispos. 2005. PMID: 15640377
-
Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.J Pharm Pharmacol. 2004 Jan;56(1):123-8. doi: 10.1211/0022357022395. J Pharm Pharmacol. 2004. PMID: 14980009
-
Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.J Pharm Pharmacol. 2019 Jan;71(1):129-138. doi: 10.1111/jphp.12858. Epub 2018 Feb 7. J Pharm Pharmacol. 2019. PMID: 29411879 Review.
-
St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.Pharm Res. 2010 May;27(5):811-22. doi: 10.1007/s11095-010-0074-1. Epub 2010 Mar 13. Pharm Res. 2010. PMID: 20229133
-
Pharmacokinetic interactions of drugs with St John's wort.J Psychopharmacol. 2004 Jun;18(2):262-76. doi: 10.1177/0269881104042632. J Psychopharmacol. 2004. PMID: 15260917 Review.
Cited by
-
Quercetin-biapigenin nanoparticles are effective to penetrate the blood-brain barrier.Drug Deliv Transl Res. 2022 Jan;12(1):267-281. doi: 10.1007/s13346-021-00917-6. Epub 2021 Mar 11. Drug Deliv Transl Res. 2022. PMID: 33709285
-
Cytotoxic and Antibacterial Prenylated Acylphloroglucinols from Hypericum olympicum L.Plants (Basel). 2023 Mar 29;12(7):1500. doi: 10.3390/plants12071500. Plants (Basel). 2023. PMID: 37050127 Free PMC article.
-
Herb-drug interactions: challenges and opportunities for improved predictions.Drug Metab Dispos. 2014 Mar;42(3):301-17. doi: 10.1124/dmd.113.055236. Epub 2013 Dec 11. Drug Metab Dispos. 2014. PMID: 24335390 Free PMC article.
-
Drug interactions with herbal medicines.Clin Pharmacokinet. 2012 Feb 1;51(2):77-104. doi: 10.2165/11597910-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22257149 Review.
-
Pharmacokinetics and hepatic uptake of gliquidone affected by Huangqi injection.Eur J Drug Metab Pharmacokinet. 2014 Dec;39(4):255-61. doi: 10.1007/s13318-013-0154-9. Epub 2013 Oct 2. Eur J Drug Metab Pharmacokinet. 2014. PMID: 24085486
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous